雾化疗法应用于小儿支气管肺炎的临床应用价值分析  

Clinical Value Analysis of Aerosol Therapy Used in Children with Bronchial Pneumonia

作　　者：赵筱昱[1] 崔璐[1] 杨霏霏[1] 

机构地区：[1]大连市友谊医院儿科,辽宁大连116100

出　　处：《中国医药指南》2016年第13期18-19,共2页Guide of China Medicine

摘　　要：目的探讨雾化疗法应用于小儿支气管肺炎的临床应用价值分析。方法选取2013年1月至2014年1月,到我院就诊的小儿支气管肺炎患者101例,随机分为试验组(51例)与对照组(50例),两组患者均给予相同的对症治疗,对照组使用氨溴索静脉滴注,试验组采用对照组的基础上使用布地奈德雾化吸入,观察两组患者呼吸频率以及氧饱和度等指标的改变。结果治疗后试验组呼吸频率以及氧饱和度指标优于对照组,差异有统计学意义(P<0.05)。结论使用雾化疗法治疗小儿支气管肺炎临床效果显著,值得在临床推广。Objective Observation on the efficacy of oxygen drive aemsol adn inistration in the treatment of Children with bronchial pneumonia. Methods 101 Children with bronchial pneumonia in our hospital were selected during January 2013 to January 2014 divided into two groups. Two groups of patients were given the same symptomatic treatment. Control group（51 cases） used expectorant, and asthma treatment. Observation group（50 cases） used Ambroxol Intravenous drip. Observation group depended on the Control group add oxygen drive aemsol adn inistration, observation breathing rate, Oxygen saturation. Results After treatment Observation group was better than the Control group, the difference was statistically significant（P〈0.05）. Conclusion The efficacy of drive aemsol adn inistration in the treatment of Children with bronchial pneumonia was well, is worth popularizing in clinical.

关 键 词：布地奈德雾化 氨溴索 小儿支气管肺炎 雾化吸入 

分 类 号：R725.6[医药卫生—儿科]